ondansetron and methotrexate

ondansetron has been researched along with methotrexate in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	16 (38.10)	18.2507
2000's	12 (28.57)	29.6817
2010's	12 (28.57)	24.3611
2020's	2 (4.76)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Campillo, NE; Guerra, A; Páez, JA	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hirschfeld, S; Jarosinski, PF	1
Bagshawe, KD; Begent, RH; Carruthers, L; Crawford, SM; Newlands, ES; Rustin, GJ; Smith, DB	1
Bagshawe, KD; Begent, RH; Howells, N; McQuade, B; Newlands, ES; Rustin, GJ; Smith, DB	1
Campora, E; Cetto, GL; Fosser, V; Mammoliti, S; Marangolo, M; Oliva, C; Rosso, R	1
Burton, G; Ciociola, AA; Cubeddu, LX; Galvin, D; Meshad, M; Pendergrass, K; Ryan, T; York, M	1
Aapro, MS; Bauer, J; Brunner, KW; Buser, KS; Cavalli, F; Haefliger, JM; Joss, RA; Jungi, WF; Obrist, R; Piquet, D	1
Latreille, J; Levitt, M; Lofters, WS; Perrault, DJ; Potvin, M; Rayner, HL; Warner, E; Warr, D; Wilson, KS; Yelle, L	1
Barrenetxea, G; Centeno, MM; de la Rica, M; Rodríguez-Escudero, FJ; Romero, H; Schneider, J	1
Ionta, MT; Massidda, B	1
Beck, TM; Chang, A; Griffin, D; Harvey, WH; Meshad, M; Navari, R; Wentz, A; York, M	1
Chavez, CM; Holdsworth, MT; Raisch, DW; Winter, SS	1
Blanco, R; García-Pais, MJ; García-Porrúa, C; González-Gay, MA; Ibañez, D; Sánchez-Andrade, A; Vázquez-Caruncho, M	1
Bleuse, JP; Block, S; Bonneterre, J; Bonneterre, ME; Carlier, D; Darloy, F; Fournier, C; Huc, P	1
Berry, D; Cavanaugh, C; Fehdrau, R; Gilbert, CJ; Hussein, A; McKinstry, C; Peters, WP; Petros, WP; Ross, M; Rubin, P; Vredenburgh, J	1
Fukui, H; Yamamoto, M	1
Ben Arush, MW; Ben-Barak, A; Elhasid, R; Levin, K; Postovsky, S	1
Fujimaki, K; Fukawa, H; Harano, H; Hashimoto, Y; Hattori, M; Kanamori, H; Kodama, F; Koharasawa, H; Mohri, H; Motomura, S; Sakai, R; Takemura, S; Tanabe, J; Tomita, N	1
Atlas, MP; Giugliano, DM; Mahan, RA; Parker, RI; Prakash, D	1
Hayakawa, H; Ishida, T; Kusaba, T	1
Buyukavci, M; Ceviz, N; Olgun, H	1
Pinsk, M; Turner, SR	1
Georgakakou, S; Giaginis, C; Kazanis, M; Koufopantelis, P; Margeli, A; Panderi, I; Papargiri, S	1
Barkey, J; Benchimol, EI; Boland, M; Kempinska, A; Mack, A; Mack, DR	1
Eksborg, S; Lönnqvist, PA; Öbrink, E; Oddby-Muhrbeck, E; Rotstein, S	1
Charro, M; Domènech, E; García-López, S; Gisbert, JP; Gomollón, F; Muñoz, F; Rubio, S	1
Bernhardt, MB	1
Lertvivatpong, N; Monsereenusorn, C; Photia, A; Rujkijyanont, P; Ruktrirong, J; Traivaree, C	1
Fida, S; Kakalia, S; Khan, HA; Kitchlew, R; Saif, S; Siddique, M	1

Reviews

1 review(s) available for ondansetron and methotrexate

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

15 trial(s) available for ondansetron and methotrexate

Article	Year
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet (London, England), 1991, Aug-24, Volume: 338, Issue:8765 Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imidazoles; Male; Methotrexate; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal; Ondansetron; Vincristine; Vomiting	1991
Oral ondansetron (GR 38032F) for the control of CMF-induced emesis in the outpatient. Breast cancer research and treatment, 1991, Volume: 19, Issue:2 Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Fluorouracil; Humans; Imidazoles; Methotrexate; Middle Aged; Ondansetron; Vomiting	1991
Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group. American journal of clinical oncology, 1994, Volume: 17, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Double-Blind Method; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Vomiting	1994
Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:6 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Double-Blind Method; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting	1993
Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil. The New England journal of medicine, 1993, Apr-15, Volume: 328, Issue:15 Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Metoclopramide; Middle Aged; Nausea; Ondansetron; Regression Analysis; Vomiting	1993
Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens. Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:5 Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Methotrexate; Metoclopramide; Ondansetron; Patient Satisfaction; Quality of Life; Surveys and Questionnaires; Vomiting	1996
Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy. Journal of chemotherapy (Florence, Italy), 1996, Volume: 8, Issue:3 Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cost-Benefit Analysis; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Granisetron; Granulocyte Colony-Stimulating Factor; Humans; Indoles; Injections, Intravenous; Methotrexate; Middle Aged; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting	1996
Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group. Cancer investigation, 1997, Volume: 15, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Appetite; Cyclophosphamide; Double-Blind Method; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Nausea; Neoplasms; Ondansetron; Time Factors; Vomiting	1997
Ondansetron prevents refractory and severe methotrexate-induced nausea in rheumatoid arthritis. British journal of rheumatology, 1998, Volume: 37, Issue:5 Topics: Antiemetics; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Male; Methotrexate; Nausea; Ondansetron; Retrospective Studies; Treatment Outcome	1998
[Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord]. Bulletin du cancer, 1998, Volume: 85, Issue:6 Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Female; Granisetron; Humans; Male; Methotrexate; Nausea; Ondansetron; Prednisone; Vindesine; Vomiting	1998
Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer. Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:6 Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Ondansetron; Prospective Studies; Transplantation Conditioning	1998
[Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associate Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2 Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Nausea; Ondansetron; Prednisolone; Prednisone; Prognosis; Vincristine; Vomiting, Anticipatory	2002
Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9 Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cross-Over Studies; Cytarabine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Hydrocortisone; Injections, Intravenous; Leukemia; Male; Mercaptopurine; Methotrexate; Nausea; Ondansetron; Risk; Serotonin Antagonists; Treatment Outcome; Vincristine; Vomiting	2001
The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia. American journal of clinical oncology, 2005, Volume: 28, Issue:2 Topics: Adolescent; Antiemetics; Antimetabolites, Antineoplastic; Child; Child, Preschool; Electrocardiography; Female; Granisetron; Heart Rate; Humans; Male; Methotrexate; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin Antagonists; Vomiting	2005
Single daily dosing versus divided dosing intravenous ondansetron to prevent chemotherapy-induced nausea and vomiting among children: A comparative randomized double-blind controlled trial. Pediatric blood & cancer, 2021, Volume: 68, Issue:6 Topics: Adolescent; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Double-Blind Method; Female; Hematologic Neoplasms; Humans; Hydrocortisone; Infant; Infant, Newborn; Male; Methotrexate; Nausea; Ondansetron; Prospective Studies; Vomiting	2021

Other Studies

26 other study(ies) available for ondansetron and methotrexate

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Cheminformatic models to predict binding affinities to human serum albumin. Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25 Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids	2001
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Precipitation of ondansetron in alkaline solutions. The New England journal of medicine, 1991, Oct-31, Volume: 325, Issue:18 Topics: Antiemetics; Bicarbonates; Chemical Precipitation; Drug Therapy, Combination; Hydrogen-Ion Concentration; Imidazoles; Methotrexate; Ondansetron; Sodium; Sodium Bicarbonate; Solutions	1991
A phase I/II study of the 5-HT3 antagonist GR38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapy. Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Imidazoles; Male; Methotrexate; Middle Aged; Ondansetron; Prognosis; Serotonin Antagonists; Vincristine; Vomiting	1990
Ondansetron vs dexamethasone for chemotherapy-induced emesis. Lancet (London, England), 1991, Aug-24, Volume: 338, Issue:8765 Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dexamethasone; Humans; Imidazoles; Methotrexate; Nausea; Ondansetron; Vincristine; Vomiting	1991
Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1998, Volume: 6, Issue:2 Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Humans; Hydrocortisone; Injections, Spinal; Male; Methotrexate; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome	1998
Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy. European journal of pharmacology, 1999, May-21, Volume: 372, Issue:3 Topics: Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Disease Models, Animal; Dogs; Female; Male; Methotrexate; Ondansetron; Vomiting	1999
Allergic reaction to high-dose methotrexate. Medical and pediatric oncology, 2000, Volume: 35, Issue:2 Topics: Adolescent; Anti-Anxiety Agents; Antimetabolites, Antineoplastic; Antipruritics; Bone Neoplasms; Diphenhydramine; Drug Eruptions; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Immunosuppressive Agents; Male; Methotrexate; Ondansetron; Osteosarcoma; Premedication; Tibia; Urticaria	2000
[Incidence of emesis in outpatients on chemotherapy for breast cancer and the clinical efficacy of ondansetron hydrochloride tablets]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:5 Topics: Ambulatory Care; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Nausea; Ondansetron; Vomiting, Anticipatory	2002
Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL. Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:1 Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cytarabine; Dexamethasone; Female; Humans; Hypokalemia; Mercaptopurine; Methotrexate; Nausea; Ondansetron; Polyethylene Glycols; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Vincristine	2008
Direct injection liquid chromatography/positive ion electrospray ionization mass spectrometric quantification of methotrexate, folinic acid, folic acid and ondansetron in human serum. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009, Nov-15, Volume: 877, Issue:30 Topics: Adolescent; Child; Child, Preschool; Chromatography, Liquid; Female; Folic Acid; Humans; Infant; Leucovorin; Male; Methotrexate; Ondansetron; Spectrometry, Mass, Electrospray Ionization	2009
Short-course ondansetron for the prevention of methotrexate-induced nausea in children with Crohn disease. Journal of pediatric gastroenterology and nutrition, 2011, Volume: 53, Issue:4 Topics: Adolescent; Case-Control Studies; Child; Crohn Disease; Dose-Response Relationship, Drug; Female; Humans; Male; Methotrexate; Nausea; Ondansetron; Ontario; Premedication; Retrospective Studies; Treatment Outcome	2011
Is there an association between PONV and chemotherapy-induced nausea and vomiting? Acta anaesthesiologica Scandinavica, 2013, Volume: 57, Issue:6 Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease Resistance; Droperidol; Epirubicin; Female; Fluorouracil; Granisetron; Humans; Mastectomy; Methotrexate; Metoclopramide; Middle Aged; Models, Biological; Narcotics; Nausea; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Risk Factors; Vomiting	2013
[Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease]. Gastroenterologia y hepatologia, 2015, Volume: 38, Issue:1 Topics: Adult; Antiemetics; Antirheumatic Agents; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Child; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Nausea; Ondansetron	2015
Nausea and vomiting: Therapeutic orphans of pediatric oncology. Pediatric blood & cancer, 2017, Volume: 64, Issue:10 Topics: Antiemetics; Child; Child, Preschool; Granisetron; Humans; Methotrexate; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin 5-HT3 Receptor Antagonists; Vomiting	2017
Role of Ondansetron in Reducing Methotrexate Intolerance in Patients with Inflammatory Arthritis. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2022, Volume: 32, Issue:10 Topics: Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Humans; Methotrexate; Nausea; Ondansetron; Treatment Outcome; Vomiting	2022